John D. McDermott, Chief Executive Officer at ENDOLOGIX INC /DE/ (ELGX), sold 13,900 shares at $15.82 ($220K) on 2013-08-01, disclosed to the SEC on 2013-08-02.
Scheduled sale ($220k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.79 | 300 | $5K | 2.2% |
| 2 | $15.80 | 100 | $2K | 0.7% |
| 3 | $15.81 | 800 | $13K | 5.7% |
| 4 | $15.81 | 700 | $11K | 5.0% |
| 5 | $15.82 | 1,300 | $21K | 9.3% |
| 6 | $15.82 | 300 |
| $5K |
| 2.2% |
| 7 | $15.82 | 1,000 | $16K | 7.2% |
| 8 | $15.83 | 2,200 | $35K | 15.8% |
| 9 | $15.83 | 200 | $3K | 1.4% |
| 10 | $15.83 | 400 | $6K | 2.9% |
| 11 | $15.83 | 1,900 | $30K | 13.7% |
| 12 | $15.84 | 400 | $6K | 2.9% |
| 13 | $15.84 | 500 | $8K | 3.6% |
| 14 | $15.84 | 300 | $5K | 2.2% |
| 15 | $15.84 | 200 | $3K | 1.4% |
| 16 | $15.84 | 1,200 | $19K | 8.6% |
| 17 | $15.84 | 1,400 | $22K | 10.1% |
| 18 | $15.85 | 200 | $3K | 1.4% |
| 19 | $15.86 | 100 | $2K | 0.7% |
| 20 | $15.86 | 300 | $5K | 2.2% |
| 21 | $15.87 | 100 | $2K | 0.7% |
| Total | $15.83 avg | 13,900 | $220K | 100% |
| Filing → |
| ELGX | SELL | 2016-06-02 | $154K | — | Filing → |
| ELGX | BUY | 2015-11-03 | $178K | — | Filing → |
| ELGX | BUY | 2014-11-05 | $281K | — | Filing → |